Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | CA12 | O43570 | 5/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA6 | P23280 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Saccharin SCHEMBL953945 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL49027 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL3372 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL10618576 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL10399957 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL787894 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL8668442 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL5870938 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL473608 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 | |
| Saccharin SCHEMBL176171 | 0.96 | GPR3 (0.44) | GPR3CA9CA12KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4392045-A1 | IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM | American Regent, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| WO-2023028252-A1 | IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM | AMERICAN REGENT, INC. (US) | 2023-03-02 | — | — | WO | claimed |
| EP-1973549-A2 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | Luitpold Pharmaceuticals, Inc. (US) | 2008-10-01 | — | — | EP | claimed |
| WO-2007081744-A2 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-19 | — | — | WO | claimed |
| US-20070161600-A1 | complexed with iron; bioavailability; anemia | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | US | claimed |
| EP-4392045-A1 | IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM | American Regent, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| CN-118103047-A | Iron compositions and methods of making and using the same | 美国瑞根特有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20230084291-A1 | IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM | AMERICAN REGENT, INC. (US) | 2023-03-16 | — | — | US | disclosed |
| WO-2023028252-A1 | IRON COMPOSITIONS AND METHODS OF MAKING AND USING THEM | AMERICAN REGENT, INC. (US) | 2023-03-02 | — | — | WO | disclosed |
| US-20230008240-A1 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | AMERICAN REGENT, INC. (US) | 2023-01-12 | — | — | US | disclosed |
| US-11364260-B2 | Methods and compositions for administration of iron | AMERICAN REGENT, INC. (US) | 2022-06-21 | — | — | US | disclosed |
| US-11344568-B2 | Methods and compositions for administration of iron | AMERICAN REGENT, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| EP-1973549-A2 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | Luitpold Pharmaceuticals, Inc. (US) | 2008-10-01 | — | — | EP | disclosed |
| WO-2008070703-A1 | APPARATUS AND METHOD FOR ISOLATING IRON COMPONENTS FROM SERUM | BAXTER INTERNATIONAL INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| US-20080132465-A1 | APPARATUS AND METHOD FOR ISOLATING IRON COMPONENTS FROM SERUM | BAXTER INTERNATIONAL INC. | 2008-06-05 | — | — | US | disclosed |
| WO-2007081744-A2 | METHODS AND COMPOSITIONS FOR ADMINISTRATION OF IRON | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-19 | — | — | WO | disclosed |
| US-20070161600-A1 | complexed with iron; bioavailability; anemia | LUITPOLD PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | US | disclosed |
| US-20050053696-A1 | Stable and bioavailable iron fortified beverages | KRAFT FOOD HOLDINGS, INC. | 2005-03-10 | — | — | US | disclosed |
| WO-2003013283-A1 | STABLE AND BIOAVAILABLE IRON FORTIFIED BEVERAGES | KRAFT FOODS HOLDINGS, INC. (US) | 2003-02-20 | — | — | WO | disclosed |
| US-20030031757-A1 | Stable and bioavailable iron fortified beverages | KRAFT FOOD HOLDINGS, INC. | 2003-02-13 | — | — | US | disclosed |